Extracellular nucleosides and nucleotides as immunomodulators-Reference-Cited by-同舟云学术

Extracellular nucleosides and nucleotides as immunomodulators

Published:2017-10-13 Issue:1 Volume:280 Page:83-92
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:Immunol Rev

Author:

Kepp Oliver¹²³⁴,Loos Friedemann¹²³⁴,Liu Peng¹²³⁴⁵,Kroemer Guido¹²³⁴⁶^ORCID

Affiliation:

1. Metabolomics and Cell Biology Platforms; Gustave Roussy Comprehensive Cancer Institute; Villejuif France

2. Equipe 11 Labellisée Ligue Contre le Cancer; Centre de Recherche des Cordeliers; INSERM U 1138; Paris France

3. Sorbonne Paris Cité; Université Paris Descartes; Paris France

4. Université Pierre et Marie Curie; Paris France

5. University of Paris Sud XI; Kremlin Bicêtre France

6. University of Paris Sud XI; Kremlin Bicêtre France. Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris France. Karolinska Institute; Department of Women's and Children's Health; Karolinska University Hospital; Stockholm Sweden

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12571/fullpdf

Reference109 articles.

1. CD39 and CD73 in immunity and inflammation;Antonioli;Trends Mol Med,2013

2. Release of adenosine triphosphate from isolated adult heart cells in response to hypoxia;Forrester;J Physiol,1977

3. Neural nomenclature;Burnstock;Nature,1971

4. Purinergic receptors in airway epithelia;Lazarowski;Curr Opin Pharmacol,2009

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative single-cell and bulk transcriptomes analyses reveals heterogeneity of serine-glycine-one-carbon metabolism with distinct prognoses and therapeutic vulnerabilities in HNSCC;International Journal of Oral Science;2024-06-17

2. Nanoparticle-mediated immunogenic cell death for cancer immunotherapy;International Journal of Pharmaceutics;2024-05

3. Human CD56+CD39+ dNK cells support fetal survival through controlling trophoblastic cell fate: immune mechanisms of recurrent early pregnancy loss;National Science Review;2024-04-11

4. Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics;Journal of Advanced Research;2024-03

5. Targeting ENPP1 depletion may be a promising therapeutic strategy for treating oral squamous cell carcinoma via cytotoxic autophagy‐related apoptosis;The FASEB Journal;2024-01-17